Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine
- PMID: 207416
Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine
Abstract
Deoxyadenosine but not adenosine reversed the antiviral activity of 9-beta-D-arabinofuranosyladenine (ara-A) and 9-beta-D-arabinofuranosylhypoxanthine (ara-H) when used in the presence of coformycin, an inhibitor of adenosine deaminase. In suspension cultures of KB cells, 10 muM ara-A inhibited the replication of herpes simplex virus type 1 by 80%. Concomitant addition of 50 muM deoxyadenosine reduced the antiviral activity of 10 muM ara-A to only 40% inhibition. Adenosine failed to antagonize the antiviral activity. In monolayer cultures of KB cells, the 50% inhibitory concentration of ara-A was increased from 1.5 to 2.9 muM by 2 muM deoxyadenosine and to 8.5 muM by 10 muM deoxyadenosine. Analysis of the dose-response data by a double reciprocal plot method indicated that the antagonism was competitive. The antiviral activity of ara-H also was antagonized by deoxyadenosine. The 50% inhibitory concentration of ara-H was increased from 42 muM to 70, 91, or 121 muM by the concurrent addition of 5, 10, or 20 muM deoxyadenosine. Competitive antagonism could not be demonstrated. In the absence of the adenosine deaminase inhibitor, neither ara-A nor ara-H was antagonized by deoxyadenosine. Since such inhibitors were not available unitl recently, previous investigators were unable to observe the antagonistic capacity of deoxyadenosine.
Similar articles
-
Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.J Lab Clin Med. 1977 Apr;89(4):687-91. J Lab Clin Med. 1977. PMID: 191546
-
Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.Cancer Res. 1989 Sep 15;49(18):4983-9. Cancer Res. 1989. PMID: 2788493
-
Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.Cancer Res. 1975 Jun;35(6):1547-54. Cancer Res. 1975. PMID: 1079475
-
Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity.Biochem Pharmacol. 1984 Aug 1;33(15):2431-8. doi: 10.1016/0006-2952(84)90715-9. Biochem Pharmacol. 1984. PMID: 6087827
-
Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.Cancer Res. 1982 May;42(5):2092-6. Cancer Res. 1982. PMID: 6175407
Cited by
-
Herpes simplex virus mutants resistant to arabinosyladenine in the presence of deoxycoformycin.Antimicrob Agents Chemother. 1984 Sep;26(3):382-7. doi: 10.1128/AAC.26.3.382. Antimicrob Agents Chemother. 1984. PMID: 6095755 Free PMC article.
-
Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells.Antimicrob Agents Chemother. 1979 Jan;15(1):101-10. doi: 10.1128/AAC.15.1.101. Antimicrob Agents Chemother. 1979. PMID: 218497 Free PMC article.
-
Antagonism of the cytotoxic but not antiviral effects of ara-sangivamycin by adenosine.Antimicrob Agents Chemother. 1989 Sep;33(9):1606-8. doi: 10.1128/AAC.33.9.1606. Antimicrob Agents Chemother. 1989. PMID: 2554803 Free PMC article.
-
Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.Cancer Chemother Pharmacol. 1980;4(4):227-35. doi: 10.1007/BF00255266. Cancer Chemother Pharmacol. 1980. PMID: 7002342 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials